Gene targeting in human pluripotent stem cells with adeno-associated virus vectors

Biochemical and Biophysical Research Communications

Volumn 388, Issue 4, 2009, Pages 711-717

  Mitsui, Kaoru ^a   Suzuki, Keiichiro ^a   Aizawa, Emi ^a   Kawase, Eihachiro ^b   Suemori, Hirofumi ^b   Nakatsuji, Norio ^b,c   Mitani, Kohnosuke ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Adeno associated virus vectors; Homologous recombination; Human embryonic stem cells; Human induced pluripotent stem cells; Hypoxanthine phosphoribosyl transferase 1; NANOG

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ENHANCED GREEN FLUORESCENT PROTEIN; GENOMIC DNA; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE 1; OCTAMER TRANSCRIPTION FACTOR 4; PARVOVIRUS VECTOR; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE STRUCTURE; GENE TARGETING; HOMOLOGOUS RECOMBINATION; HPRT 1 GENE; HUMAN; HUMAN CELL; HUMAN INDUCED PLURIPOTENT STEM CELL; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NANOG GENE; NONHUMAN; PLASMID; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCID MOUSE; SOUTHERN BLOTTING; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

DEPENDOVIRUS; GENE TARGETING; GENETIC VECTORS; HOMEODOMAIN PROTEINS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; PLURIPOTENT STEM CELLS;

ADENO-ASSOCIATED VIRUS;

EID: 69949113994     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.075     Document Type: Article

References (38)

1. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
2. Suemori H., Yasuchika K., Hasegawa K., Fujioka T., Tsuneyoshi N., and Nakatsuji N. Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem. Biophys. Res. Commun. 345 (2006) 926-932
3. Yu J., and Thomson J.A. Pluripotent stem cell lines. Genes Dev. 22 (2008) 1987-1997
4. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
5. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin II, and Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
6. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N., and Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26 (2008) 101-106
7. Zwaka T.P., and Thomson J.A. Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 21 (2003) 319-321
8. Urbach A., Schuldiner M., and Benvenisty N. Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem cells 22 (2004) 635-641
9. Costa M., Dottori M., Sourris K., Jamshidi P., Hatzistavrou T., Davis R., Azzola L., Jackson S., Lim S.M., Pera M., Elefanty A.G., and Stanley E.G. A method for genetic modification of human embryonic stem cells using electroporation. Nat. Protoc. 2 (2007) 792-796
10. Irion S., Luche H., Gadue P., Fehling H.J., Kennedy M., and Keller G. Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat. Biotechnol. 25 (2007) 1477-1482
11. Lombardo A., Genovese P., Beausejour C.M., Colleoni S., Lee Y.L., Kim K.A., Ando D., Urnov F.D., Galli C., Gregory P.D., Holmes M.C., and Naldini L. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25 (2007) 1298-1306
12. Braam S.R., Denning C., van den Brink S., Kats P., Hochstenbach R., Passier R., and Mummery C.L. Improved genetic manipulation of human embryonic stem cells. Nat. Methods 5 (2008) 389-392
13. Davis R.P., Ng E.S., Costa M., Mossman A.K., Sourris K., Elefanty A.G., and Stanley E.G. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 111 (2008) 1876-1884
14. Di Domenico A.I., Christodoulou I., Pells S.C., McWhir J., and Thomson A.J. Sequential genetic modification of the hprt locus in human ESCs combining gene targeting and recombinase-mediated cassette exchange. Cloning Stem Cells 10 (2008) 217-230
15. Suzuki K., Mitsui K., Aizawa E., Hasegawa K., Kawase E., Yamagishi T., Shimizu Y., Suemori H., Nakatsuji N., and Mitani K. Highly efficient transient gene expression, gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors. Proc. Natl. Acad. Sci. USA 105 (2008) 13781-13786
16. Zou J., Maeder M.L., Mali P., Pruett-Miller S.M., Thibodeau-Beganny S., Chou B.K., Chen G., Ye Z., Park I.H., Daley G.Q., Porteus M.H., Joung J.K., and Cheng L. Gene targeting of a disease-related gene in human induced pluripotent stem, embryonic stem cells. Cell Stem Cell 5 (2009) 97-110
17. Amit M., Carpenter M.K., Inokuma M.S., Chiu C.P., Harris C.P., Waknitz M.A., Itskovitz-Eldor J., and Thomson J.A. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227 (2000) 271-278
18. Hasegawa K., Fujioka T., Nakamura Y., Nakatsuji N., and Suemori H. A method for the selection of human embryonic stem cell sublines with high replating efficiency after single-cell dissociation. Stem Cells 24 (2006) 2649-2660
19. Russell D.W., and Hirata R.K. Human gene targeting by viral vectors. Nat. Genet. 18 (1998) 325-330
20. Hirata R., Chamberlain J., Dong R., and Russell D.W. Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat. Biotechnol. 20 (2002) 735-738
21. Hendrie P.C., Hirata R.K., and Russell D.W. Chromosomal integration and homologous gene targeting by replication-incompetent vectors based on the autonomous parvovirus minute virus of mice. J. Virol. 77 (2003) 13136-13145
22. Russell D.W., and Hirata R.K. Human gene targeting favors insertions over deletions. Hum. Gene Ther. 19 (2008) 907-914
23. Hendrie P.C., and Russell D.W. Gene targeting with viral vectors. Mol. Ther. 12 (2005) 9-17
24. Vasileva A., and Jessberger R. Precise hit: adeno-associated virus in gene targeting. Nat. Rev. Microbiol. 3 (2005) 837-847
25. Fu H., Muenzer J., Samulski R.J., Breese G., Sifford J., Zeng X., and McCarty D.M. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol. Ther. 8 (2003) 911-917
26. Rabinowitz J.E., Rolling F., Li C., Conrath H., Xiao W., Xiao X., and Samulski R.J. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76 (2002) 791-801
27. Gao G.P., Alvira M.R., Wang L., Calcedo R., Johnston J., and Wilson J.M. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99 (2002) 11854-11859
28. Zolotukhin S., Byrne B.J., Mason E., Zolotukhin I., Potter M., Chesnut K., Summerford C., Samulski R.J., and Muzyczka N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene. Ther. 6 (1999) 973-985
29. Watanabe K., Ueno M., Kamiya D., Nishiyama A., Matsumura M., Wataya T., Takahashi J.B., Nishikawa S., Muguruma K., and Sasai Y. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25 (2007) 681-686
30. Wu Z., Asokan A., and Samulski R.J. Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol. Ther. 14 (2006) 316-327
31. Buning H., Perabo L., Coutelle O., Quadt-Humme S., and Hallek M. Recent developments in adeno-associated virus vector technology. J. Gene Med. 10 (2008) 717-733
32. Hart A.H., Hartley L., Ibrahim M., and Robb L. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev. Dyn. 230 (2004) 187-198
33. Mountford P., Zevnik B., Duwel A., Nichols J., Li M., Dani C., Robertson M., Chambers I., and Smith A. Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc. Natl. Acad. Sci. USA 91 (1994) 4303-4307
34. Baker D.E., Harrison N.J., Maltby E., Smith K., Moore H.D., Shaw P.J., Heath P.R., Holden H., and Andrews P.W. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 25 (2007) 207-215
35. Dong J.Y., Fan P.D., and Frizzell R.A. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7 (1996) 2101-2112
36. Chamberlain J.R., Schwarze U., Wang P.R., Hirata R.K., Hankenson K.D., Pace J.M., Underwood R.A., Song K.M., Sussman M., Byers P.H., and Russell D.W. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303 (2004) 1198-1201
37. Chamberlain J.R., Deyle D.R., Schwarze U., Wang P., Hirata R.K., Li Y., Byers P.H., and Russell DW D.W. Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta. Mol Ther 16 (2008) 187-193
38. Ohbayashi F., Balamotis M.A., Kishimoto A., Aizawa E., Diaz A., Hasty P., Graham F.L., Caskey C.T., and Mitani K. Correction of chromosomal mutation, random integration in embryonic stem cells with helper-dependent adenoviral vectors. Proc. Natl. Acad. Sci. USA 102 (2005) 13628-13633